Reticulate Pigmented Anomaly Treatment & Management

1. Dowling GD, Freudenthal W. Acanthosis nigricans. Proc Roy Soc Med. 1938. 31:1147-50.

2. Degos R, Ossipowski B. [Reticulated pigmentary dermatosis of the folds: relation to acanthosis nigricans.]. Ann Dermatol Syphiligr (Paris). 1954 Mar-Apr. 81(2):147-51. [QxMD MEDLINE Link].

3. Stephan C, Kurban M, Abbas O. Dowling-Degos disease: a review. Int J Dermatol. 2020 Dec 23. [QxMD MEDLINE Link].

4. Hanneken S, Rütten A, Pasternack SM, Eigelshoven S, El Shabrawi-Caelen L, Wenzel J, et al. Systematic mutation screening of KRT5 supports the hypothesis that Galli-Galli disease is a variant of Dowling-Degos disease. Br J Dermatol. 2010 Mar 5. [QxMD MEDLINE Link].

5. Hanneken S, Rütten A, Eigelshoven S, Braun-Falco M, Pasternack SM, Ruzicka T, et al. [Galli-Galli disease. Clinical and histopathological investigation using a case series of 18 patients]. Hautarzt. 2011 Nov. 62(11):842-51. [QxMD MEDLINE Link].

6. Basmanav FB, Oprisoreanu AM, Pasternack SM, Thiele H, Fritz G, Wenzel J, et al. Mutations in POGLUT1, encoding protein O-glucosyltransferase 1, cause autosomal-dominant Dowling-Degos disease. Am J Hum Genet. 2014 Jan 2. 94(1):135-43. [QxMD MEDLINE Link]. [Full Text].

7. Basmanav FB, Fritz G, Lestringant GG, Pachat D, Hoffjan S, Fischer J, et al. Pathogenicity of POFUT1 in Dowling-Degos disease: additional mutations and clinical overlap with reticulate acropigmentation of kitamura. J Invest Dermatol. 2015 Feb. 135(2):615-8. [QxMD MEDLINE Link].

8. Kono M, Suganuma M, Takama H, Zarzoso I, Saritha M, Bodet D, et al. Dowling-Degos disease with mutations in POFUT1 is clinico-pathologically distinct from reticulate acropigmentation of Kitamura. Br J Dermatol. 2015 Feb 1. [QxMD MEDLINE Link].

9. Duchatelet S, Clerc H, Machet L, Gaboriaud P, Miskinyte S, Kervarrec T, et al. A new nonsense mutation in the POGLUT1 gene in two sisters with Dowling-Degos disease. J Eur Acad Dermatol Venereol. 2018 Mar 23. [QxMD MEDLINE Link].

10. Kono M, Sawada M, Nakazawa Y, Ogi T, Muro Y, Akiyama M. A Japanese Case of Galli-Galli Disease due to a Previously Unreported POGLUT1 Mutation. Acta Derm Venereol. 2019 Apr 1. 99 (4):458-459. [QxMD MEDLINE Link].

11. García-Gil MF, Monte Serrano J, Ramirez-Lluch M, Valero Torres A, López-Giménez MT, Lezcano Biosca V. A novel mutation in POFUT1 gene associated with Dowling-Degos disease and hidradenitis suppurativa. Int J Dermatol. 2021 Jan. 60 (1):e25-e27. [QxMD MEDLINE Link].

12. Ren J, Zeng LY. Scrotal Dowling-Degos disease caused by a novel frameshift variant in gamma-secretase subunit presenile enhancer gene. Australas J Dermatol. 2020 Nov. 61 (4):e399-e402. [QxMD MEDLINE Link].

13. Müller CS, Pföhler C, Tilgen W. Changing a concept--controversy on the confusing spectrum of the reticulate pigmented disorders of the skin. J Cutan Pathol. 2009 Jan. 36(1):44-8. [QxMD MEDLINE Link].

14. El Shabrawi-Caelen L, Rütten A, Kerl H. The expanding spectrum of Galli-Galli disease. J Am Acad Dermatol. 2007 May. 56(5 Suppl):S86-91. [QxMD MEDLINE Link].

15. Brown WG. Reticulate pigmented anomaly of the flexures. Case reports and genetic investigation. Arch Dermatol. 1982 Jul. 118(7):490-3. [QxMD MEDLINE Link].

16. Yu W, Gan L, Wu J, Sun J, Jiang Y. Dowling-Degos disease with mutation in the exon 1 of the keratin 5 gene. J Eur Acad Dermatol Venereol. 2017 Jun 24. [QxMD MEDLINE Link].

17. Li CR, Xing QH, Li M, et al. A gene locus responsible for reticulate pigmented anomaly of the flexures maps to chromosome 17p13.3. J Invest Dermatol. 2006 Jun. 126(6):1297-301. [QxMD MEDLINE Link].

18. Betz RC, Planko L, Eigelshoven S, et al. Loss-of-function mutations in the keratin 5 gene lead to Dowling-Degos disease. Am J Hum Genet. 2006 Mar. 78(3):510-9. [QxMD MEDLINE Link].

19. Liao H, Zhao Y, Baty DU, McGrath JA, Mellerio JE, McLean WH. A heterozygous frameshift mutation in the V1 domain of keratin 5 in a family with Dowling-Degos disease. J Invest Dermatol. 2007 Feb. 127(2):298-300. [QxMD MEDLINE Link].

20. Bedlow AJ, Mortimer PS. Dowling-Degos disease associated with hidradenitis suppurativa. Clin Exp Dermatol. 1996 Jul. 21(4):305-6. [QxMD MEDLINE Link].

21. Fenske NA, Groover CE, Lober CW, Espinoza CG. Dowling-Degos disease, hidradenitis suppurativa, and multiple keratoacanthomas. A disorder that may be caused by a single underlying defect in pilosebaceous epithelial proliferation. J Am Acad Dermatol. 1991 May. 24(5 Pt 2):888-92. [QxMD MEDLINE Link].

22. Khaddar RK, Mahjoub WK, Zaraa I, Sassi MB, Osman AB, Debbiche AC, et al. [Extensive Dowling-Degos disease following long term PUVA therapy]. Ann Dermatol Venereol. 2012 Jan. 139(1):54-7. [QxMD MEDLINE Link].

23. Jones EW, Grice K. Reticulate pigmented anomaly of the flexures. Dowing Degos disease, a new genodermatosis. Arch Dermatol. 1978 Aug. 114(8):1150-7. [QxMD MEDLINE Link].

24. Kim YC, Davis MD, Schanbacher CF, Su WP. Dowling-Degos disease (reticulate pigmented anomaly of the flexures): a clinical and histopathologic study of 6 cases. J Am Acad Dermatol. 1999 Mar. 40(3):462-7. [QxMD MEDLINE Link].

25. Zuo YG, Ho M, Jin HZ, Wang BX. Case report: a case of newborn onset reticulate pigmented anomaly of the flexures in a Chinese female. J Eur Acad Dermatol Venereol. 2008 Jul. 22(7):901-3. [QxMD MEDLINE Link].

26. Sandhu K, Saraswat A, Kanwar AJ. Dowling-Degos disease with dyschromatosis universalis hereditaria-like pigmentation in a family. J Eur Acad Dermatol Venereol. 2004 Nov. 18(6):702-4. [QxMD MEDLINE Link].

27. Loo WJ, Rytina E, Todd PM. Hidradenitis suppurativa, Dowling-Degos and multiple epidermal cysts: a new follicular occlusion triad. Clin Exp Dermatol. 2004 Nov. 29(6):622-4. [QxMD MEDLINE Link].

28. Naveen KN, Athaniker SB, Hegde SP, Shetty R, Radha H, Parinitha SS. Atypical cases of Dowling-Degos disease. Indian Dermatol Online J. 2016 Mar-Apr. 7 (2):99-102. [QxMD MEDLINE Link].

29. Ghosh A, Kumar P, Das A. Generalized Dowling-Degos disease with hypopigmented lesions: A diagnostic challenge. Indian J Dermatol Venereol Leprol. 2018 Jan-Feb. 84 (1):70-72. [QxMD MEDLINE Link].

30. Singh S, Khandpur S, Verma P, Singh M. Follicular Dowling Degos disease: a rare variant of an evolving dermatosis. Indian J Dermatol Venereol Leprol. 2013 Nov-Dec. 79(6):802-4. [QxMD MEDLINE Link].

31. Schwartz RA, Birnkrant AP, Burgess GH, Stoll HL Jr, Yaqub M, Fox MD. Reticulate pigmented anomaly. Cutis. 1980 Oct. 26(4):380-1. [QxMD MEDLINE Link].

32. Batycka-Baran A, Baran W, Hryncewicz-Gwozdz A, Burgdorf W. Dowling-Degos disease: case report and review of the literature. Dermatology. 2010. 220(3):254-8. [QxMD MEDLINE Link].

33. Taskapan O, Gokce E, Akin O, Erkilinc AC, Demirkesen C. Dowling-Degos disease with diffuse penile pigmentation. J Eur Acad Dermatol Venereol. 2014 Jan 15. [QxMD MEDLINE Link].

34. O'Goshi K, Terui T, Tagami H. Dowling-Degos disease affecting the vulva. Acta Derm Venereol. 2001 May. 81(2):148. [QxMD MEDLINE Link].

35. Massone C, Hofmann-Wellenhof R. Dermoscopy of Dowling-Degos disease of the vulva. Arch Dermatol. 2008 Mar. 144(3):417-8. [QxMD MEDLINE Link].

36. Coco V, Guerriero C, Esposito I, De Vincenzo RP, Peris K. A familial case of Dowling-Degos disease on the vulva. Clin Exp Dermatol. 2019 Jan 21. [QxMD MEDLINE Link].

37. Lee SJ, Lee HJ, Kim DW, Jun JB, Chung SL, Bae HI. A case of Dowling-Degos disease suggesting an evolutional sequence. J Dermatol. 2000 Sep. 27(9):591-7. [QxMD MEDLINE Link].

38. Nishizawa A, Nakano H, Satoh T, Takayama K, Sawamura D, Yokozeki H. Haber's syndrome may be a clinical entity different from Dowling-Degos disease. Br J Dermatol. 2009 Jan. 160(1):215-7. [QxMD MEDLINE Link].

39. Braun-Falco M, Volgger W, Borelli S, Ring J, Disch R. Galli-Galli disease: an unrecognized entity or an acantholytic variant of Dowling-Degos disease?. J Am Acad Dermatol. 2001 Nov. 45(5):760-3. [QxMD MEDLINE Link].

40. Gilchrist H, Jackson S, Morse L, Nicotri T, Nesbitt LT. Galli-Galli disease: A case report with review of the literature. J Am Acad Dermatol. 2008 Feb. 58(2):299-302. [QxMD MEDLINE Link].

41. Ee HL, Tan SH. Reticulate hyperpigmented scleroderma: a new pigmentary manifestation. Clin Exp Dermatol. 2005 Mar. 30(2):131-3. [QxMD MEDLINE Link].

42. Shen Z, Chen L, Ye Q, Hao F, Vitorino Mdos S, Yang X, et al. Coexistent Dowling-Degos disease and reticulate acropigmentation of kitamura with progressive seborrheic keratosis. Cutis. 2011 Feb. 87(2):73-5. [QxMD MEDLINE Link].

43. Rongioletti F, Fausti V, Christana K, Montinari M, Parodi A, Fiocca R. Atypical Variant of Galli-Galli Disease (Grover-Like Eruption With Lentiginous Freckling) in a Liver Transplant Patient. Am J Dermatopathol. 2011 Jan 19. [QxMD MEDLINE Link].

44. Müller CS, Tremezaygues L, Pföhler C, Vogt T. The spectrum of reticulate pigment disorders of the skin revisited. Eur J Dermatol. 2012 Sep-Oct. 22(5):596-604. [QxMD MEDLINE Link].

45. Strausburg M, Linos K, Staser K, Mousdicas N. Dowling-Degos disease co-presenting with Darier disease. Clin Exp Dermatol. 2016 Jun. 41 (4):410-2. [QxMD MEDLINE Link].

46. Knuever J, Persa OD, Illerhaus A, Ralser DJ, Hartmann K, Betz RC, et al. Mast cell activation in Dowling-Degos disease. Br J Dermatol. 2019 Dec. 181 (6):1312-1314. [QxMD MEDLINE Link].

47. Zhang RZ, Zhu WY. A study of immunohistochemical and electron microscopic changes in Dowling-Degos disease. J Dermatol. 2005 Jan. 32(1):12-8. [QxMD MEDLINE Link].

48. Yun JH, Kim JH, Choi JS, Roh JY, Lee JR. Treatment of Dowling-Degos disease with fractional Er:YAG laser. J Cosmet Laser Ther. 2013 Mar 6. [QxMD MEDLINE Link].

49. Tambe SA, Patil PD, Saple DG. Successful Management of Dowling-Degos Disease with Combination of Q-switched Nd: YAG and Fractional Carbon Dioxide Laser. J Cutan Aesthet Surg. 2017 Jan-Mar. 10 (1):60-62. [QxMD MEDLINE Link].

50. Gupta A, Huilgol SC. Successful treatment of Dowling-Degos disease using intense pulsed light. Australas J Dermatol. 2014 Dec 13. [QxMD MEDLINE Link].

51. Drut R, Pollono D, Drut RM. Bilateral nephroblastoma in familial Hay-Wells syndrome associated with familial reticulate pigmentation of the skin. Am J Med Genet. 2002 Jun 15. 110(2):164-9. [QxMD MEDLINE Link].

Robert A Schwartz, MD, MPH Professor and Head of Dermatology, Professor of Pathology, Professor of Pediatrics, Professor of Medicine, Rutgers New Jersey Medical School

Robert A Schwartz, MD, MPH is a member of the following medical societies: Alpha Omega Alpha, American Academy of Dermatology, New York Academy of Medicine, Royal College of Physicians of Edinburgh, Sigma Xi, The Scientific Research Honor Society

Disclosure: Nothing to disclose.

David F Butler, MD Former Section Chief of Dermatology, Central Texas Veterans Healthcare System; Professor of Dermatology, Texas A&M University College of Medicine; Founding Chair, Department of Dermatology, Scott and White Clinic

David F Butler, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Dermatology, Association of Military Dermatologists, Phi Beta Kappa, Texas Dermatological Society

Disclosure: Nothing to disclose.

Warren R Heymann, MD Head, Division of Dermatology, Professor, Department of Internal Medicine, Rutgers New Jersey Medical School

Warren R Heymann, MD is a member of the following medical societies: American Academy of Dermatology, American Society of Dermatopathology, Society for Investigative Dermatology

Disclosure: Nothing to disclose.

William D James, MD Paul R Gross Professor of Dermatology, Vice-Chairman, Residency Program Director, Department of Dermatology, University of Pennsylvania School of Medicine

William D James, MD is a member of the following medical societies: American Academy of Dermatology, Society for Investigative Dermatology

Disclosure: Received income in an amount equal to or greater than $250 from: Elsevier; WebMD<br/>Served as a speaker for various universities, dermatology societies, and dermatology departments.

Mark A Crowe, MD Assistant Clinical Instructor, Department of Medicine, Division of Dermatology, University of Washington School of Medicine

Mark A Crowe, MD is a member of the following medical societies: American Academy of Dermatology and North American Clinical Dermatologic Society

Disclosure: Nothing to disclose.

Borys Savchyk, MD, PhD Director, Molecular Biology Institute, Medical University of Lviv, Ukraine

Disclosure: Nothing to disclose.

Alexander Zajchenko, MD Head, Professor, Department of Skin and Venereal Diseases, Medical University of Lviv, Ukraine

Disclosure: Nothing to disclose.

• Print this section
• Print the entire contents of
• Print the entire contents of article